Some Newer Treatment Options for Type 2 Diabetes

被引:0
作者
Josse, Robert G. [1 ,2 ]
机构
[1] St Michaels Hosp, Div Endocrinol & Metab, 30 Bond St, Toronto, ON M5B 1W8, Canada
[2] Univ Toronto, Med, Toronto, ON, Canada
来源
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2015年 / 22卷 / 12期
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:1363 / 1363
页数:1
相关论文
共 7 条
[1]  
[Anonymous], 2015, DIABETES CARE, V38, P140
[2]   Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence [J].
Fonseca, Vivian A. ;
Handelsman, Yehuda ;
Staels, Bart .
DIABETES OBESITY & METABOLISM, 2010, 12 (05) :384-392
[3]  
Graziano, 2010, DIABETES CARE, V33, P1503
[4]  
Hasan, DIABETES RES CLIN PR, V104, P297
[5]   Bromocriptine: old drug, new formulation and new indication [J].
Holt, R. I. G. ;
Barnett, A. H. ;
Bailey, C. J. .
DIABETES OBESITY & METABOLISM, 2010, 12 (12) :1048-1057
[6]  
Kahn SE, 2015, DIABETOLOGI IN PRESS
[7]   SGLT inhibitors in management of diabetes [J].
Tahrani, Abd A. ;
Barnett, Anthony H. ;
Bailey, Clifford J. .
LANCET DIABETES & ENDOCRINOLOGY, 2013, 1 (02) :140-151